Clinical Trial Update: Phase II Clinical Trial to Evaluate the Ongoing Pregnancy Rate With OXO-001 in IVF/ICSI With Donor Oocytes. [Phase 2]

View source ↗

Summary

Phase II clinical trial update reports completion of a study evaluating ongoing pregnancy rates with OXO-001 in IVF/ICSI using donor oocytes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• OXO-001 (OXO-001)

Snippet

Sponsor: OXOLIFE | Conditions: Infertility, Female, Infertility | Phase 2 | Status: COMPLETED